302-18: Psychotropic Medications & Impact on the Bone

4.86 (7 votes)

302-18:  Psychotropic Medications & Impact on the Bone

This researcher explains how preliminary research demonstrates a negative effect of serotonin on bone health.  While the use of antipsychotic and antidepressant medications may have harmful side effects on bone, there are new ideas of how to mitigate this risk.


Presenter:
  Karen L. Houseknecht, PhD

Disclosures: The presenter and planners have no conflict of interest or commercial support to disclose. Off-label uses will be discussed during this presentation.


Session Length:
 1 hour 2 minutes

Target Audience:  RN, APRN


Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

  1. Describe the pharmacology underlying effects of psychotropic medications on metabolic and bone health.
  2. Explore the impact of off-label prescribing on metabolic burden and bone health in patients taking antipsychotic medications.

Keywords: Bone Health, APRN Practice, Psychopharmacology, Serotonin


Continuing Nursing Education:
1.0 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


Originally Presented
APNA 16th Annual Clinical Psychopharmacology Institute
Baltimore, Maryland
Sunday, June 10, 2018
9:45am - 11:15am

The contact hours for this session expire: December 31, 2020

Components visible upon registration.